Distinguishing Bacterial from Fungal Intertrigo
Bacterial intertrigo presents with painful, exudative, macerated erosions or ulcers with yellow-green discharge and putrid odor, while fungal (candidal) intertrigo typically shows erythematous patches with satellite lesions and peripheral scaling without the characteristic foul smell.
Clinical Differentiation
Bacterial Intertrigo Features 1, 2
- Pain is the predominant symptom (not primarily itching)
- Yellow-green exudate with putrid, foul odor
- Macerated erosions or ulcers in toe webs or skin folds
- Edema and inflammation
- May progress to cellulitis if untreated
- Often polymicrobial: Pseudomonas aeruginosa (most common), Enterococcus faecalis, Staphylococcus aureus 2
- Autoeczematization occurs in 50% of cases 2
Fungal (Candidal) Intertrigo Features 3, 4
- Itching is the predominant symptom
- Erythematous patches with satellite lesions (pathognomonic)
- Peripheral scaling
- Moist, macerated appearance but typically less exudative
- No foul odor
- Affects skin folds: groin, axillae, inframammary, interdigital spaces
Diagnostic Approach
Clinical diagnosis is usually sufficient 1, 4. However, when presentation is atypical or treatment-resistant:
- KOH preparation: Identifies fungal elements (pseudohyphae and budding yeast for Candida) 4
- Bacterial culture: Only needed if bacterial infection suspected or treatment fails 1
- Wood lamp examination: Coral-red fluorescence suggests Corynebacterium minutissimum (erythrasma) 4
Common pitfall: Superficial swabs are not always diagnostically required or relevant in bacterial intertrigo 1. The clinical presentation is often sufficient to guide initial therapy.
Treatment Algorithms
For Fungal (Candidal) Intertrigo 3, 4
First-line topical therapy:
- Nystatin, clotrimazole, ketoconazole, oxiconazole, or econazole applied twice daily
- Duration: 2-4 weeks until resolution
For resistant or extensive disease:
Essential adjunctive measures:
- Keep affected areas dry
- Use absorptive powders (cornstarch)
- Barrier creams
- Address predisposing factors (obesity, diabetes, immunosuppression) 3
For Bacterial Intertrigo 1, 2
Local therapy (primary approach):
- Anti-inflammatory agents
- Antiseptic solutions
- Dry wound care
- Edema reduction
- Proper foot hygiene
Systemic antibiotics indicated ONLY for:
- Associated soft-tissue infection (cellulitis/phlegmon)
- In immunocompetent patients: coverage for S. aureus is sufficient 1
- Consider anti-pseudomonal coverage if severe or immunocompromised
Critical distinction: Superficial bacterial intertrigo does NOT require systemic antibiotics 1. Reserve antibiotics for true soft-tissue extension.
Key Management Principles
Address Predisposing Factors 3, 7, 8
- Weight loss for obesity
- Glycemic control for diabetes
- Light, nonconstricting, absorbent clothing
- Avoid wool and synthetic fibers
- Open-toed shoes for toe web involvement
- Shower after exercise and dry thoroughly
- Consider moisture-wicking textiles in skin folds 8
Common Pitfalls to Avoid
- Misdiagnosing bacterial intertrigo as fungal: Leads to treatment failure and potential progression to cellulitis
- Using combination antifungal-corticosteroids indiscriminately: Promotes resistance and may worsen bacterial infections 9
- Prescribing systemic antibiotics for superficial bacterial intertrigo: Unnecessary antibiotic exposure 1
- Ignoring underlying conditions: Diabetes, peripheral arterial disease, and immunosuppression facilitate both occurrence and recurrence 1, 3
When to Escalate Care 1
Immediate vascular evaluation, imaging, and surgical assessment required for:
- Deep infection
- Necrosis
- Signs of systemic toxicity
- Diabetic patients with neuropathy or vascular disease